Welcome to Mælandsmo's Group
The research group is studying biological and therapeutic aspects of the metastatic process, the principle cause of death in cancer patients. Our goal is to extend the knowledge about how the individual steps in this complicated process are regulated, and subsequently use this information for identification of potential target molecules that can be utilized in cancer therapy.
Professor Gunhild M. Mælandsmo, who is the administrative group leader.
The group is member of the Center for Research Based Innovation, Cancer Stem Cell Innovation Center (CAST)., and the K.G. Jebsen centre for Breast Cancer Research http://www.med.uio.no/klinmed/forskning/sentre/kgj-brystkreftforskning/om/kontakt/.
Contact information
The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Phone: +47 22 78 18 79(Mælandsmo) +47 22 78 12 68(Dept. secretary), Fax: +47 22 78 17 95
Email: gunhildm@rr-research.no
Print this page [9426 visits]Christos Samakovlis: The molecular basis of airway maturation in Drosophila
Jan 17, 2012
Latest publications
Metastasis: biology and therapy group
In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts
J Magn Reson Imaging (in press)
PubMed 22170753
Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
Tumour Biol, 33 (1), 73-83
PubMed 22006279
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
Breast Cancer Res, 13 (4), R75
PubMed 21816090
More publications
